Search

everythinglearnresearchcommunity

for

Search:↓

DPP may help hair regrowth by improving blood vessel function under stress.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Castration helped a dog with a tumor and hair loss by normalizing hormone levels and regrowing hair.

Both contraceptive pill doses effectively reduced androgen levels in women with PCOS.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

The eucalyptus oil system improved skin delivery of hormones, but safety concerns remain.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Estetrol may help prevent hair loss and promote hair growth in women.

Male tissue has more cell death than female tissue after ischemia, and some neurosteroids only protect female cells.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

PRP may improve fertility treatment success but needs more research for safe use.

Steroid hormones change the size, charge, and stability of DPPC liposomes.

Medroxyprogesterone acetate iontophoresis safely and effectively reduces facial hair growth in women.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth and could be a target for treating hair loss.

Neuroimaging suggests that treatments targeting brain steroids could help control epilepsy, especially types linked to the menstrual cycle.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Measuring 17-hydroxyprogesterone in hair can help monitor androgen levels in people with congenital adrenal hyperplasia.

Human placenta extract may promote hair growth by affecting certain lipid compounds.

Prostaglandin F2α may help treat hair loss by promoting hair growth.

Injected bimatoprost 0.03% solution did not effectively treat female-pattern hair loss.

A new compound that could treat various androgen-related conditions was created and analyzed.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

Pro-, pre-, and synbiotics may help with PCOS, but more research is needed.